| Identification | Back Directory | [Name]
(E)-2-((5-(4-nitrophenyl)furan-2-yl)methylene)hydrazine-1-carbothioamide | [CAS]
1632320-78-5 | [Synonyms]
F8-S43-S3
(E)-2-((5-(4-nitrophenyl)furan-2-yl)methylene)hydrazine-1-carbothioamide
(2E)-2-{[5-(4-nitrophenyl)furan-2-yl]methylidene}hydrazinecarbothioamide
Hydrazinecarbothioamide, 2-[[5-(4-nitrophenyl)-2-furanyl]methylene]-, (2E)- | [Molecular Formula]
C12H10N4O3S | [MDL Number]
MFCD00695942 | [MOL File]
1632320-78-5.mol | [Molecular Weight]
290.3 |
| Hazard Information | Back Directory | [Uses]
F8-S43-S3 is an inhibitor of SARS-CoV-2 main protease, with an IC50 of 9.69 μM[1]. | [References]
[1] Dou X, et, al. Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease. Eur J Med Chem. 2022 Aug 5;238:114508. DOI:10.1016/j.ejmech.2022.114508 |
|
| Company Name: |
OTAVA chemicals
|
| Tel: |
416 305 9979 (Canada) |
| Website: |
www.otavachemicals.com |
| Company Name: |
PHARMEKS Ltd.
|
| Tel: |
+7 (495) 702-9648 |
| Website: |
www.pharmeks.com |
|